share_log

Revolution Medicines Shares Are Trading Lower. The Company Provided Key Clinical Updates From Its RAS(ON) Inhibitor Portfolio.

Revolution Medicines Shares Are Trading Lower. The Company Provided Key Clinical Updates From Its RAS(ON) Inhibitor Portfolio.

revolution medicines的股票價格正在下跌。公司提供了其RAS(ON)抑制劑組合的重要臨床更新。
Benzinga ·  2024/12/02 23:10

Revolution Medicines Shares Are Trading Lower. The Company Provided Key Clinical Updates From Its RAS(ON) Inhibitor Portfolio.

Revolution Medicines的股票正在下跌。公司提供了其RAS(ON)抑制劑組合的關鍵臨床更新。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論